Boston Scientific (BSX) Income from Continuing Operations (2009 - 2026)

Boston Scientific (BSX) has 18 years of Income from Continuing Operations data on file, last reported at 1338000000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations rose 99.11% year-over-year to 1338000000.0; the trailing twelve-month figure through Mar 2026 stood at 3559000000.0 (up 75.75% YoY), and the FY2025 full-year result was 2892000000.0, up 56.66% from the prior year.
• Income from Continuing Operations improved to 1338000000.0 in Q1 2026, from 670000000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 1338000000.0 in Q1 2026 to a low of 111000000.0 in Q1 2022.
• A 5-year average of 492294117.65 and a median of 493000000.0 in 2024 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations sank 67.45% in 2022 and surged 257.45% in 2023, its largest moves.
• Tracing BSX's Income from Continuing Operations over 5 years: stood at 141000000.0 in 2022, then surged by 257.45% to 504000000.0 in 2023, then gained by 11.51% to 562000000.0 in 2024, then climbed by 19.22% to 670000000.0 in 2025, then jumped by 99.7% to 1338000000.0 in 2026.
• Business Quant data shows BSX's Income from Continuing Operations at 1338000000.0 in Q1 2026, 670000000.0 in Q4 2025, and 756000000.0 in Q3 2025.